Share

Hi ,

Our ability to read, write, and edit DNA is what makes synthetic biology possible. As our understanding of DNA rapidly evolves and the science behind DNA synthesis improves, we're gaining a better understanding of how to utilize and implement technologies like CRISPR, cell-free manufacturing, protein design, and DNA data storage, What started as a dream of engineering has now enabled us to cure diseases, produce sustainable chemicals, store data in molecules, and create highly-valuable proteins not found in nature. What will we create next through the power of DNA?

This newsletter is brought to you by Inscripta, a life science technology company committed to creating a cleaner, healthier, and more sustainable world through biomanufacturing. A global leader in genome engineering, their innovations are designed to unlock the full potential of the bioeconomy.

We have put together a list of everything you need to know about reading, writing & editing DNA, and the major developments in the last year. Join the discussion at SynBioBeta 2023: The Global Synthetic Biology Conference May 23 - 25, and the track dedicated to this topic.

Francis deSouza, Illumina’s CEO, says the more powerful model will be able to sequence 20,000 genomes per year; its current machines can do about 7,500. He will be giving a keynote speech at SynBioBeta 2023.

  • Ten years of CRISPR: June marked ten years since CRISPR-Cas9 was repurposed as a gene editing system. From gene drives to screens, and diagnostics to therapeutics, CRISPR nucleic acids and the Cas enzymes with which they’re frequently paired have revolutionized how scientists tinker with DNA and RNA.
  • Todd R. Nelson, Dan Gibson and the whole Telesis Bio team announced the commercial release of the BioXp™ 9600 system – a fully automated, high-throughput benchtop platform for synthetic biology workflows designed to empower scientists to accelerate discovery of new vaccines and biologics. They will be speaking more about it at SynBioBeta 2023 on May 24 at 2:45 PM.

Dan Gibson, CTO of Telesis Bio.

Molecular Assemblies ships out DNA orders to its first customers.

DNA enzymatic synthesis represents an enormously valuable next step in harnessing the power of DNA replication and our ability to use it for developing cutting-edge, biotechnology solutions. Image: Canva/Science Photo Library.

Reading, Writing & Editing DNA at SynBioBeta:

Here are some of the upcoming sessions:

Related Sponsors

We hope you enjoyed this Reading, Writing & Editing DNA wrap up newsletter and I hope that you’ll choose to join us in May at SynBioBeta 2023: The Global Synthetic Biology Conference.

Register now

Regards,
John

---

John Cumbers
Founder, SynBioBeta

View in Browser »

SynBioBeta, LLC
3559 Mount Diablo Boulevard #2, Lafayette, CA 94549

info@synbiobeta.com

If you no longer wish to receive our emails, you can unsubscribe here.
Modify Your Email Preferences


Email Marketing by ActiveCampaign